Bone Density After 50: What's Normal and What's Not

What does a "normal" bone density result actually mean after 50?

A normal bone density result is a T-score between +1 and -1 — meaning your bone density is close to that of a healthy young adult. The Royal Osteoporosis Society defines the bands clearly: +1 to -1 is normal, -1 to -2.5 is osteopenia (lower-than-peak density that is "expected in older adults"), and -2.5 or below is osteoporosis.

The important nuance after 50 is that a perfectly "young adult" score becomes less common with age — and a score in the osteopenia range does not, by itself, mean you are heading for a fracture. The same source is explicit that bone density results "do not give a complete picture of your bone strength" and should be paired with an assessment of your overall fracture risk. In other words, a number on a scan is the start of the conversation, not the verdict.

What are T-scores and Z-scores, and which one matters at your age?

A T-score compares your bone density to a healthy young adult; a Z-score compares it to people your own age and sex. For most people over 50, the T-score is the figure used to classify bone health, because the diagnostic bands above are built around it.

Osteoporosis is diagnosed on the basis of a bone mineral density T-score at the total hip, femoral neck or lumbar spine, according to the 2024 UK NOGG clinical guideline. The Z-score is more useful in younger people or when looking for a secondary cause of bone loss, where comparing against age-matched peers is more meaningful than comparing against a 30-year-old. After 50, expect your clinician to lead with the T-score — but to interpret it in the context of your age, history and risk factors rather than reading it in isolation.

How fast do women lose bone density during perimenopause and after menopause?

Bone loss accelerates around the menopause transition because falling oestrogen removes one of the skeleton's main protective signals. This is why menopause is such a pivotal moment for bone health, and why so many women first hear the word "osteopenia" in their early fifties.

How fast? It varies a great deal between individuals. Early data indicates the loss can be substantial in some women during perimenopause specifically: in a small observational study, average bone density fell by roughly 4% over 24 months, and a subgroup were "fast bone losers" who lost considerably more (PeKnO Study, 2022). That study followed just 49 women, so the figure is best read as illustrative of how quickly some women lose bone — not a population-wide average.

The bigger picture is sobering but motivating. Across a lifetime, one in two women and one in five men over 50 will experience a fragility fracture, and the UK sees around 549,000 new fragility fractures each year — including roughly 105,000 hip fractures and 86,000 vertebral fractures (NOGG, 2024). The years around menopause are exactly when knowing your numbers is most valuable, because that's when the trajectory often changes. If you're navigating this transition, our menopause and bone health series goes deeper.

When does a low T-score cross the line from "watch and wait" to "act now"?

There is no single magic number — UK guidance bases treatment decisions on your overall fracture risk, not on the T-score alone. A T-score of -2.5 or below confirms osteoporosis by definition, but that is not the same as an automatic prescription, and people with higher T-scores can still warrant treatment if their other risk factors stack up.

For context on how common a low score is at this age: the prevalence of a femoral neck T-score of -2.5 or below, in those aged 50 and older, is 6.8% in men and 21.8% in women, according to the NOGG guideline. So roughly one in five women over 50 meets the density threshold for osteoporosis — but whether that means "act now" depends on the fuller fracture-risk picture below. The practical line between "watch and wait" and "act now" is drawn by your clinician, weighing your density against your history, not by a single decimal on a printout.

What does a fracture risk assessment add that a T-score alone cannot tell you?

A fracture risk assessment combines your bone density with the things a scan can't see — your age, weight, smoking, steroid use, family history and previous fractures — to estimate your actual 10-year risk of breaking a bone. This is what turns a number into a decision.

UK practice uses validated tools to do this. NICE guideline CG146 recommends using either FRAX or QFracture to estimate 10-year predicted absolute fracture risk. The same guideline advises clinicians not to routinely assess fracture risk in people under 50 unless they have major risk factors — such as current or frequent recent use of oral or systemic glucocorticoids, untreated premature menopause, or a previous fragility fracture. After 50, that calculus changes, and risk assessment becomes a sensible default.

This is also why two people with an identical T-score can get very different advice: someone with extra risk factors sits at a higher fracture risk than a fit peer with the same density number — and that gap is exactly what the assessment reveals. You can read more on our bone health assessment page.

What can you actually do to slow bone loss after 50 — and what does the evidence say?

The combination with the strongest supporting evidence is exercise plus adequate calcium and vitamin D — together, not in isolation. This is reassuring, because it means much of what protects bone after 50 is within your control.

A 2025 systematic review and meta-analysis in Nutrients compared combined exercise plus calcium/vitamin D against supplementation alone in postmenopausal women, and found the combined approach produced greater improvements in bone density at both the lumbar spine and femoral neck (Bai et al., 2025). The effect was a standardised effect size rather than a fixed percentage, and weight-bearing or vibration-based loading appeared to drive the largest gains — underlining that how you load your skeleton matters, not just what you swallow.

On the nutrition side, the UK NOGG guideline points to a minimum of 700 mg of calcium daily, and at least 800 IU/day of vitamin D where there is vitamin D insufficiency. For women aged 60 or under at high fracture risk, the same guideline lists HRT as a first-line treatment option — a decision to make with your GP, weighing benefits and risks for you specifically.

In practical terms, that means resistance and weight-bearing training a few times a week, enough dietary protein, calcium and vitamin D sufficiency, and a baseline scan so you can actually see whether your efforts are working.

How often should you have a bone density scan, and are there radiation-free options?

There is no fixed schedule for everyone — frequency depends on your results and risk factors — but monitoring scans are commonly repeated every one to two years. The right interval is a clinical judgement, not a calendar rule.

The standard NHS test is DEXA, which uses a small dose of X-ray radiation, and is typically offered to people over 50 with a risk of developing osteoporosis, with postmenopausal women particularly at risk (NHS). DEXA is well established, though the Royal Osteoporosis Society notes it can become less accurate with age — particularly over 75 — as spinal changes interfere with the reading.

Why a radiation-free REMS scan suits repeat monitoring

Because DEXA uses radiation, frequent re-scanning is less than ideal. REMS (Radiofrequency Echographic Multi Spectrometry) uses ultrasound instead of X-rays, so it is radiation-free and can be repeated safely — which is exactly what tracking change after 50 calls for. Early evidence is encouraging: a 2025 consensus paper described REMS as a non-ionising approach with reported sensitivity and specificity for osteoporosis above 90%, recommended where DEXA is contraindicated such as pregnancy or spinal implants (Zambito et al., 2025), and a small primary-care study found REMS results associated with confirmed diagnoses at the spine and femur (Vieira & Santos, 2025).

These studies are small and at an early, feasibility stage, so REMS is best understood as an emerging, monitoring-friendly assessment rather than a proven drop-in replacement for clinical DEXA. You can read how we approach the technology on our REMS technology and scientific approach pages, or compare REMS and DEXA.

Where do you go next if your results show osteopenia or osteoporosis in the UK?

If a scan shows osteopenia or osteoporosis, the next step is a conversation with your GP about your fracture risk and whether treatment, lifestyle change, or simply monitoring is right for you. A diagnosis is information, not a sentence — and for many people in the osteopenia range it means focusing on prevention rather than starting medication.

The stakes are real: UK direct costs of fragility fractures reached £5.4 billion in 2019, and fractures cost independence as much as money (NOGG, 2024). The lever you can pull is early knowledge — finding out where you stand while there is most room to act.

If you'd like a clear starting point, Book a screening — a radiation-free bone health assessment — explore our biodensity screening and assessment days, or see where we screen across the UK. To understand the thinking behind our approach, visit our about and experts pages.

---

This article is part of our menopause and bone health series. If you're also weighing up weight-loss medications, see Do Ozempic and weight-loss injections cause bone loss? and our wider bone health guides.